Aqr Capital Management LLC Biomarin Pharmaceutical Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 598,500 shares of BMRN stock, worth $40.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

598,500

Previous 55,372 980.87%

Holding current value

$40.2 Million

Previous $4.56 Million 822.95%

% of portfolio

0.06%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $37.5 Million - $51 Million	543,128 Added 980.87%	598,500 $42.1 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $2.43 Million - $3.02 Million	32,709 Added 144.33%	55,372 $4.56 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $2.88 Million - $3.41 Million	-34,410 Reduced 60.29%	22,663 $1.98 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $2.44 Million - $3.15 Million	-31,984 Reduced 35.91%	57,073 $5.5 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $7.34 Million - $8.16 Million	-86,329 Reduced 49.22%	89,057 $7.88 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $8.64 Million - $10 Million	99,686 Added 131.69%	175,386 $15.2 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $2.24 Million - $2.99 Million	25,505 Added 50.81%	75,700 $7.36 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $1.71 Million - $2.29 Million	21,108 Added 72.57%	50,195 $5.19 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.73 Million - $2.04 Million	21,038 Added 261.37%	29,087 $2.47 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $138,599 - $168,402	1,939 Added 31.73%	8,049 $663,000
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $282,932 - $353,056	3,809 Added 165.54%	6,110 $471,000
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $75,592 - $96,409	-1,054 Reduced 31.42%	2,301 $203,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $523,165 - $598,033	-6,997 Reduced 67.59%	3,355 $259,000
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $226,605 - $254,454	3,001 Added 40.82%	10,352 $860,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $1.74 Million - $2.11 Million	-23,264 Reduced 75.99%	7,351 $555,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $5.58 Million - $6.93 Million	-76,861 Reduced 71.51%	30,615 $2.63 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $6.71 Million - $12.2 Million	93,421 Added 664.68%	107,476 $8.18 Million
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $544,917 - $850,907	6,850 Added 95.07%	14,055 $1.73 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $555,900 - $754,364	-7,789 Reduced 51.95%	7,205 $595,000
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $963,664 - $1.3 Million	14,994 New	14,994 $1.26 Million

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Biomarin Pharmaceutical Inc Transaction History